Immunogenicity and Protective Efficacy of Recombinant Human T-Cell Leukemia/Lymphoma Virus Type 1 NYVAC and Naked DNA Vaccine Candidates in Squirrel Monkeys (Saimiri sciureus)

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

1984 • 886 citations

NYVAC: A highly attenuated strain of vaccinia virus

1992 • 473 citations

Infective dermatitis of Jamaican children: a marker for HTLV-I infection

1990 • 452 citations

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1999 • 384 citations

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

1997 • 364 citations

HTLV-1 AND POLYMYOSITIS IN JAMAICA

1989 • 336 citations

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1997 • 314 citations

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1998 • 227 citations

Immunization of non-human primates with DNA vaccines

1997 • 223 citations

Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIV_mac251: Dependence on Route of Challenge Exposure

1998 • 146 citations

Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.

1987 • 134 citations

Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL

1993 • 114 citations

DNA immunization

1996 • 89 citations

Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo

1987 • 85 citations

A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity

1997 • 83 citations

An HTLV-I/II Vaccine: From Animal Models to Clinical Trials?

1996 • 73 citations

Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 RecombinantSalmonellaVaccines, Induce Long-Lasting Protection in Rhesus Macaques

1995 • 64 citations

Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier.

1990 • 64 citations

Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene

1992 • 63 citations

Lymphoid Organs as a Major Reservoir for Human T-Cell Leukemia Virus Type 1 in Experimentally Infected Squirrel Monkeys (Saimiri sciureus): Provirus Expression, Persistence, and Humoral and Cellular Immune Responses

2000 • 61 citations

Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization

1994 • 61 citations

Multiple Immunizations with Attenuated Poxvirus HIV Type 2 Recombinants and Subunit Boosts Required for Protection of Rhesus Macaques

1996 • 51 citations

Highly Attenuated HTLV Type IenvPoxvirus Vaccines Induce Protection against a Cell-Associated HTLV Type I Challenge in Rabbits

1995 • 50 citations

Maternal Transmisson of HTLV‐1 Other than through Breast Milk: Discrepancy between the Polymerase Chain Reaction Positivity of Cord Blood Samples for HTLV‐1 and the Subsequent Seropositivity of Individuals

1992 • 49 citations

Infection of rats with human T‐cell leukemia virus type‐I: Susceptibility of inbred strains, antibody response and provirus location

1994 • 44 citations

The cytotoxic T-lymphocyte response to HTLV-I: the main determinant of disease?

1996 • 42 citations

HTLV-I Infection in Squirrel Monkeys (Saı̈miri sciureus) Using Autologous, Homologous, or Heterologous HTLV-I-Transformed Cell Lines

1997 • 39 citations

Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.

1997 • 37 citations

Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.

1994 • 29 citations

Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I-env gene

1997 • 24 citations

Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.

1990 • 24 citations

Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T‐cell lymphotropic virus type I

1995 • 18 citations

Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.

1989 • 13 citations

Induction of Neutralizing Antibodies Against HTLV-I Envelope Proteins After Combined Genetic and Protein Immunizations in Mice

1997 • 13 citations

Seroprevalence of HTLV‐I in portugal and evidence of double retrovirus infection of a healthy donor

1989 • 12 citations

Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice

2000 • 11 citations

Cited By (0)

Loading...